Degradation of ATM-Independent Decatenation Checkpoint Function in Human Cells is Secondary to Inactivation of p53 and Correlated with Chromosomal Destabilization
Kaufmann, William K., Campbell, Christine B., Simpson, Dennis A., Deming, Paula B., Filatov, Leonid, Galloway, Denise A., Zhao, Xiu J., Creighton, Andrew M., Downes, C. Stephen
Published in Cell cycle (Georgetown, Tex.) (01.05.2002)
Published in Cell cycle (Georgetown, Tex.) (01.05.2002)
Get full text
Journal Article
A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
Downes, C. Stephen, Clarke, Duncan J, Mullinger, Ann M, Giménez-Abián, Juan F, Creighton, Andrew M, Johnson, Robert T
Published in Nature (London) (01.12.1994)
Published in Nature (London) (01.12.1994)
Get full text
Journal Article
Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159 : A Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines
SEHESTED, M, WESSEL, I, JENSEN, L. H, HOLM, B, OLIVERI, R. S, KENWRICK, S, CREIGHTON, A. M, NITISS, J. L, JENSEN, P. B
Published in Cancer research (Chicago, Ill.) (01.04.1998)
Get full text
Published in Cancer research (Chicago, Ill.) (01.04.1998)
Journal Article
Radioactive labeling of recombinant antibody fragments by phosphorylation using human casein kinase II and [γ- 32 P]-ATP
Neri, Dario, Petrul, Heike, Winter, Greg, Light, Yvonne, Marais, Richard, Britton, Keith E, Creighton, Andrew M
Published in Nature biotechnology (01.04.1996)
Published in Nature biotechnology (01.04.1996)
Get full text
Journal Article
A QSAR study comparing the cytotoxicity and DNA topoisomerase II inhibitory effects of bisdioxopiperazine analogs of ICRF-187 (dexrazoxane)
Hasinoff, Brian B., Kuschak, Theodore I., Yalowich, Jack C., Creighton, Andrew M.
Published in Biochemical pharmacology (28.09.1995)
Published in Biochemical pharmacology (28.09.1995)
Get full text
Journal Article
Characterization of a Chinese hamster ovary cell line with acquired resistance to the bisdioxopiperazine dexrazoxane (ICRF-187) catalytic inhibitor of topoisomerase II
Hasinoff, Brian B., Kuschak, Theodore I., Creighton, Andrew M., Fattman, Cheryl L., Allan, William P., Thampatty, Padmakumari, Yalowich, Jack C.
Published in Biochemical pharmacology (15.06.1997)
Published in Biochemical pharmacology (15.06.1997)
Get full text
Journal Article
Differentiation of U-937 promonocytic cells by etoposide and ICRF-193, two antitumour DNA topoisomerase II inhibitors with different mechanisms of action
Pérez, C, Vilaboa, N E, García-Bermejo, L, de Blas, E, Creighton, A M, Aller, P
Published in Journal of cell science (01.02.1997)
Published in Journal of cell science (01.02.1997)
Get full text
Journal Article
Recombinant Anti-Human Melanoma Antibodies Are Versatile Molecules
Vola, Roberto, Rivella, Anna, Creighton, Andrew M., Neri, Dario, Natali, Pier Giorgio, Petrul, Heike, Soldani, Patrizia, Nicotra, Maria Rita, Neri, Paolo, Mariani, Massimo
Published in Journal of investigative dermatology (01.08.1996)
Published in Journal of investigative dermatology (01.08.1996)
Get full text
Journal Article
Erratum: A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
Downes, C. Stephen, Clarke, Duncan J., Mullinger, Ann M., Giménez-Abián, Juan F., Creighton, Andrew M., Johnson, Robert T.
Published in Nature (London) (01.12.1994)
Published in Nature (London) (01.12.1994)
Get full text
Journal Article
A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
Downes, C. Stephen, Clarke, Duncan J, Mullinger, Ann M, Giménez-Abián, Juan F, Creighton, Andrew M, Johnson, Robert T
Published in Nature (London) (15.12.1994)
Published in Nature (London) (15.12.1994)
Get full text
Journal Article
The protective activity of ICRF-187 against doxorubicin-induced cardiotoxicity in the rat
Yeung, T K, Jaenke, R S, Wilding, D, Creighton, A M, Hopewell, J W
Published in Cancer chemotherapy and pharmacology (01.01.1992)
Published in Cancer chemotherapy and pharmacology (01.01.1992)
Get more information
Journal Article